In Indo - drugs cost nothing and they use generics. Not the place to launch a new category molecule. What is there stategy - doesnt make sense.
Any trial in Indo cannot be used in other countries
They havent even started there registration trials.
It could take 5 years. How much money will this company need to survive over this time
In Indo - drugs cost nothing and they use generics. Not the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.0¢ | $21.54K | 57.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3248 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 49884 | 1 |
View Market Depth
| Last trade - 14.27pm 30/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |